The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Yuki Katagiri

Showing 1-20 of 22 articles
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska J, Bullett N, Ahmed N, Al-Lamee K, Al-Lamee R, Leclerc G, Kitslaar P, Dijkstra J, Reiber J, Poon E, Bourantas C, Gijsen F, Serruys P, Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabate M, Laugwitz K, Windecker S, Kastrati A, Serruys P
March 20, 2020 | 10.4244/EIJ-D-18-01080
Coronary interventions
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Coronary interventions
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y, Serruys P, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska J, Chevalier B, Mintz G, Stone G, Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Coronary interventions
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabate M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial
Modolo R, Chichareon P, Kogame N, Asano T, Chang C, de Winter R, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman O, Van Es G-A, Morel M, Onuma Y, Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00499
Coronary interventions
Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years
Tenekecioglu E, Torii R, Katagiri Y, Asano T, Modolo R, Miyazaki Y, Chichareon P, Poon E, Gijsen F, Thondapu V, van Klaveren D, Jonker H, Ooi A, Barlis P, Collet C, Onuma Y, Bourantas C, Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00381
Coronary interventions
On-line three-dimensional OFDI guided PCI vs. angiography guided in bifurcation lesions: design and rationale of the randomized OPTIMUM trial
Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y
July 9, 2019 | 10.4244/EIJ-D-18-00902
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska J, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Iñiguez A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Coronary interventions
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials
Katagiri Y, Serruys P, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska J, Piek J, Onuma Y
May 20, 2019 | 10.4244/EIJ-D-18-00607
Coronary interventions
Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P
May 7, 2019 | 10.4244/EIJ-D-18-01201
Coronary interventions
Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs
Onuma Y, Katagiri Y, Burzotta F, Holm N.R., Amabile N, Okamura T, Mintz G, Darremont O, Flensted Lassen J, Lefèvre T, Louvard Y, Stankovic G, Serruys P
February 7, 2019 | 10.4244/EIJ-D-18-00391
Coronary interventions
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang C, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska J, Piek J, Serruys P, Onuma Y, Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Coronary interventions
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y, Onuma Y, Asano T, Iñiguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabate M, Windecker S, Serruys P, Räber L, Sabate M, Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Coronary interventions
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J, Abizaid A, Ormiston J, Chevalier B, Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
STEMI
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter R, Wykrzykowska J, Brugaletta S, Räber L, Sabate M, Windecker S, Dijkstra J, Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabate M, Onuma Y, Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Coronary interventions
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J
July 20, 2018 | 10.4244/EIJ-D-17-01152
Coronary interventions
Interventional cardiology: review of the year 2017
Modolo R, Miyazaki Y, Chichareon P, Asano T, Collet C, Tenekecioglu E, Katagiri Y, Soliman O, Garg S, Onuma Y, Serruys P
April 20, 2018 | 10.4244/EIJ-D-18-00066
A novel synchronised diastolic injection method to reduce contrast volume during aortography for aortic regurgitation assessment: in vitro experiment of a transcatheter heart valve model
Miyazaki Y, Abdelghani M, de Boer E, Aben J-P, van Sloun M, Suchecki T, van 't Veer M, Collet C, Asano T, Katagiri Y, Tenekecioglu E, Soliman O, Onuma Y, de Winter R, Tonino P, van de Vosse F, Rutten M, Serruys P
December 20, 2017 | 10.4244/EIJ-D-17-00355

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Ahead of print: Leaflex Study
September 23, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
PCR Trials
VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more
(The Trials book is supported by Biotronik)
August 28, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Steady-state hyperaemia
G.G. Toth
September 18, 2020
JAA
This Week's JAA's: Biograde Study, Advances in valvular heart interventions...
September 22, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke